Animal Medication Co. Sued Over Dog Arthritis Treatment Risks

By Emily Field · October 10, 2024, 7:20 PM EDT

New Jersey-based animal medication company Zoetis Inc. was hit with a proposed class action Wednesday alleging that a drug used to treat osteoarthritis in dogs has harmful effects such as seizures,...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

HARTNEY v. ZOETIS, INC.

Case Number

Court

New Jersey

Nature of Suit

Prop. Damage Prod. Liability

Date Filed

October 09, 2024

Recent Articles By Emily

August 26, 2024
Rival Can't Avoid Drugmaker's False Ad Claim Over Pain Med
August 21, 2024
Spine Implant Caused Patient's TB, Suit Says
July 23, 2024
Meet The Lead Ozempic Lawyers
June 24, 2024
Ark. AG Sues Pharmacy Benefit Managers Over Opioids
May 03, 2024
6 States Strike $270M Opioid Deal With Amneal
April 17, 2024
FDA's Foot-Dragging On Menthol Ban Sparks Frustration
March 26, 2024
Opioid Public Nuisance Claims 'Unique,' Ohio High Court Told
March 25, 2024
What To Watch As Opioid Litigation Goes To Ohio High Court
March 11, 2024
FDA Seeks $7.2B For Fiscal Year 2025
March 07, 2024
Sens. Tell Stores To Get Illegal E-Cigs Off Their Shelves